Our Translational Research Platform for Kidney Disease
SBH SCIENCESKidney Disease Research Center
We partner with industry and academic institutions to support drug development across a broad range of kidney disease indications by providing comprehensive disease modeling state-of-the-art functional assays, and biomarker discovery and development services.
Our In-Vitro Models, Biomarker Platforms, and Functional Assays
We have developed a platform of functional assays in a growing range of in vitro models to support drug development programs for key indications in renal disease drug development including:
- Diabetic Kidney Disease (DKD)
- IgA Nephropathy (IgAN)
- Focal Segmental Glomerulosclerosis (FSGS)
- Lupus Nephritis (LN)
- Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Conditionally Immortalized Human Podocytes
- Cytoskeletal architecture and foot process analysis
- Podocyte survival and detachment
- Podocyte mitochondrial function and metabolic stress
- Slit diaphragm integrity
- Human podocytes disease-specific readout panel
Primary Human Proximal Tubule Epithelial Cells (hPTECs)
- Tubule injury and cytotoxicity
- Mitochondrial respiration and metabolism
- Fibrosis - TGF-β–driven fibrotic response
- Oxidative stress and Autophagy
- Tubular cell morphology
Human Primary Kidney Fibroblasts
- Myofibroblast activation
- Profibrotic signaling
- Kidney Inflammation
- Metabolic stress and mitochondrial injury
Biofluid Protein Biomarkers
| Biomarker | Indication | Biofluid |
|---|---|---|
| Nephrin (NPHS1) | Glomerular Injury | Urine |
| Podocalyxin (PODXL) | Glomerular Injury | Urine |
| APOL1 protein | Glomerular Injury | Urine/Plasma |
| Synaptopodin | Glomerular Injury | Urine |
| KIM-1 (HAVCR1) | Proximal Tubule Injury | Urine |
| NGAL (LCN2) | Proximal Tubule Injury | Urine/Plasma |
| Clusterin | Proximal Tubule Injury | Urine |
| IL-18 | Proximal Tubule Injury | Urine |
| NAG | Proximal Tubule Injury | Urine |
| PRO-C3 |
Fibrosis and Remodeling |
Plasma |
| PRO-C6 | Fibrosis and Remodeling | Plasma |
| TIMP-1 | Fibrosis and Remodeling | Plasma/Urine |
| MMP-2/MMP-9 | Fibrosis and Remodeling | Plasma/Urine |
| Galectin-3 | Fibrosis and Remodeling | Plasma |
| CTGF (CCN2) | Fibrosis and Remodeling | Plasma/Urine |
| CCL2 (MCP-1) | Inflammation/Immune | Urine |
| CXCL10 (IP-10) | Inflammation/Immune | Urine |
| sCD163 | Inflammation/Immune | Urine |
| IL-6 | Inflammation/Immune | Urine |
Kidney-Specific Urinary Extracellular Vesicle (EV)-Based Biomarkers
| Cell of Origin | Disease | |
|---|---|---|
| Podosin (NPHS2) | Podocyte | FSGS, DKD |
| Synaptopodin | Podocyte | FSGS, DKD |
|
WT1 |
Podocyte | DKD, IgAN |
|
Na⁺/K⁺-ATPase α1 (ATP1A1) |
Proximal Tubule |
DKD |
| NCC (SLC12A3) |
Distal tubule |
CKD |
|
AQP1 |
Proximal tubule | DKD, ADPKD |
|
AQP2 |
Collecting duct | ADPKD |
|
miR-21 |
Fibroblast EV | CKD fibrosis |
|
miR-29 |
Fibroblast EV |
Anti-fibrotic response |
| miR-192 | PTEC EV | DKD metabolic stress |
| miR-146a | Immune EV | LN, IgAN |
